Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context
Summary: Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate addictive behaviours and nicotine craving. Previo...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
Elsevier
2024-02-01
|
叢編: | EClinicalMedicine |
主題: | |
在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2589537024000087 |